In vitro Biotransfonnation of U-89843 and Its Deuterated Analog, U-141030
Loading...
Authors
Perdue, Aaron M.
Issue Date
1998
Type
Thesis
Language
en_US
Keywords
Alternative Title
Abstract
U-89843 is an important member of a lipid peroxidation family that are important
biologically. This drug was initially pursued by Pharmacia & Upjohn, Inc. for the
treatment of asthma. However, due to its observed genotoxicity, it is no longer considered
a drug candidate. Therefore, U-89843 and its deuterated analog, U-141030, were studied
in vitro in rat and human hepatic microsomes to determine characteristics of the
biotransformation of U-89843 so the mechanistic pathway that forms its reactive
intermediate can be determined. With this knowledge, it is hoped that new drug analogs
of U-89843 can be developed that are not genotoxic but still prove valuable for the
treatment of asthma. The measured isotope effect for the formation of U-97924 was
found to be 1.25 and 1.2 at 0.27 and 0.5 µM P450, respectively. These values are
indicative of a secondary isotope effect. A secondary isotope effect leads one to believe
that the mechanism responsible for the formation of U-97924 from U-89843 involves
electron abstraction followed by the addition of OH from water. Km and V max were
determined for U-89843 and U-141030 in untreated, pooled rat microsomes (Km = 4.09
µM and Vmax = 18.18 nmol/mg/min; Km= 3.36 µM and Vmax = 17.86 nmol/mg/min,
respectively) and human microsomes (Km = 21.87 µM and V max = 0.93 nmol/mg/min; Km= 8.80 µM and V max = 0.33 nmol/mg/min, respectively). The human P450 isoform
responsible for the biotransformation of U-89843 was found to be CYP3A4.
Description
vii, 47 p.
Citation
Publisher
License
U.S. copyright laws protect this material. Commercial use or distribution of this material is not permitted without prior written permission of the copyright holder. All rights reserved.